endpts.com·Jul 15, 2026
Attovia Therapeutics has filed for an initial public offering (IPO) as part of a growing trend of biotech companies seeking to go public. This marks the third biotech firm preparing for a listing in the upcoming weeks, reflecting increasing momentum in the sector.
Attovia Therapeutics, a biologics maker, has filed for an initial public offering, contributing to the growing momentum of biotech listings. This move could signal a favorable environment for biotech IPOs, presenting potential investment opportunities in the sector.